InflaRx to Report First Quarter 2026 Results on May 7, 2026
Summary
JENA, Germany, May 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting ...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.